Objective: To report the FDA approval of subcutaneous isatuximab-irfc for multiple myeloma. Approach: Indications: Approved for use in combination with pomalido
The FDA approved subcutaneous isatuximab-irfc for three indications in adult patients with multiple myeloma.
Isatuximab-irfc is approved with pomalidomide and dexamethasone for patients with prior therapy including lenalidomide.
The drug is also approved with carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.
For newly diagnosed multiple myeloma patients not eligible for stem cell transplantation, it is approved with bortezomib, lenalidomide, and dexamethasone.
The recommended dose is 1,400 mg subcutaneously, with warnings for hypersensitivity, neutropenia, and other risks.
Objective: To highlight federal actions by CMS and FDA that may impact physician practice in 2026. Approach: 2026 Medicare Physician Fee Schedule Final Rule: Fi
The 2026 Medicare Physician Fee Schedule final rule establishes separate conversion factors for qualifying and nonqualifying alternative payment model participants.
The 2026 Medicare Advantage and Part D final rule implements changes to prescription drug coverage and eliminates cost-sharing for certain adult vaccines.
CMS finalized a 2.6% update to payment rates for hospital outpatient services and ambulatory surgical centers meeting quality reporting requirements.
The FDA approved Foundayo, an oral GLP-1 therapy, for weight management in adults with obesity or overweight and related comorbid conditions.
The FDA cleared Dexcom’s Stelo Glucose Biosensor System for over-the-counter use by children aged 2 years and older who do not use insulin.
Objective: To compare the efficacy of Hyruan ONE, hylan G-F 20, and saline in reducing pain and improving function in patients with symptomatic knee osteoarthri
Objective: To introduce the JenaValve Trilogy Transcatheter Heart Valve System as a minimally invasive treatment option for patients with aortic regurgitation.
Objective: To discuss the rising rates of congenital syphilis in the US and the need for improved testing strategies to protect mothers and infants. Approach: C
Objective: To identify immune antibodies that appear earlier than current laboratory markers of Lyme disease and assess their potential in diagnosing acute and
Objective: To address the myopia epidemic and evaluate the limitations of conventional vision correction methods compared to surgical options, emphasizing the n
Objective: To investigate the association between neighborhood disadvantage and visual difficulty and blindness. Approach: Study Design: Cross-sectional study a
Objective: To explore the changing partnership models within the biopharma ecosystem. Approach: Gavin Murdoch, SVP of Commercial Strategy, Abzena: Discusses the
Objective: To determine the prevalence of bacteriospermia and examine its association with semen parameters among males attending a fertility clinic in Kumasi,
Objective: To summarize the functional phenotypes and metabolic characteristics of macrophages in the context of obesity-related metabolic diseases. Approach: R
Objective: To synthesize educational theory and propose an integrated training model for perioperative point-of-care ultrasound (POCUS). Approach: Search Strate
Point-of-care ultrasound (POCUS) is essential in perioperative medicine for real-time assessment of various clinical conditions.
POCUS education in anesthesiology is inconsistent, with barriers including faculty expertise, training time, and equipment access.
Simulation-based education is proposed as an effective method for teaching POCUS before high-stakes clinical examinations.
An integrated training model for POCUS includes six simulation-based education approaches, emphasizing cognitive preparation and team-based decision-making.
Key research priorities include validating competency thresholds and studying the impact of simulation training on clinical performance and patient outcomes.
Objective: To describe two unusual cases of siblings affected by recurrent intrahepatic cholestasis type 1 (RIC1) and to present genetic evidence of novel ATP8B
Objective: To evaluate whether serum and urinary Golgi membrane protein 1 (GOLM1/GP73) could serve as biomarkers for chronic kidney disease (CKD). Approach: Stu
Objective: To evaluate the real-world acute effects of finerenone on blood pressure (BP) and heart rate (HR) in hospitalized patients with type 2 diabetes (T2D)
Objective: To evaluate the effects of oral PQQ supplementation on ovarian reserve and related clinical and biochemical outcomes in healthy women. Approach: Stud
Objective: To explore the latent profiles of alexithymia among patients with COPD and to analyze their associated factors. Approach: Study Design: Cross-section
Objective: To identify risk factors for postoperative leptomeningeal disease (LMD) development in patients with brain metastases (BM) who underwent surgical tre